Home LiteratureArticle Details
PMID: 7224593 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Evidence for a "dying-back" gliopathy in demyelinating disease.

Annals of neurology ·Vol. 9 ·No. 3 ·1981-03-00 ·Pages 301-5

Ludwin SK, Johnson ES

Abstract

Recurrent demyelination was produced in mice by Cuprizone administration. During the second course of Cuprizone, the animals showed greater resistance to the toxin and demyelination occurred slowly and was complete only after prolonged periods. The earliest changes in oligodendrocytes occurred in the most distal processes, the inner cytoplasmic tongues, which showed degenerative changes 3 to 4 weeks before degeneration of the oligodendrocyte cell bodies or demyelination occurred. The results show for the first time that in demyelinating disease, a "dying-back" process similar to that described in axonal disease can affect the oligodendrocyte.

MeSH Terms
Animals Axons/ultrastructure Cerebellum/pathology Demyelinating Diseases/pathology Male Mice Neuroglia/ultrastructure Oligodendroglia/ultrastructure
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ludwin S K
Johnson E S
Article Info
Journal
Annals of neurology
Abbr.
Ann Neurol
ISSN
0364-5134
Published
1981-03-00
Pages
301-5
Language
English
Region
United States
NLM ID
7707449
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com